RIBOLIFE-B

06938

----

Current ValuationThe current P/E ratio is -47.15, within the reasonable range, cheaper than 74.09% of the time in the past 1 years, and the industry ranks 69/78, the industry Median -5.47.

-47.15xP/E

Stock priceHK$54.30Earnings per shareHK$-1.15

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0163326489652

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
09926HKAKESO	-88.35x	83.33%	HK$98.38B
09688HKZAI LAB	-15.15x	505.86%	HK$22.36B
07666HKMETIS TECHBIO-P	-53.81x	96.70%	HK$21.90B
01877HKJUNSHI BIO	-40.09x	84.85%	HK$18.55B
09606HKDUALITYBIO-B	-10.79x	85.58%	HK$17.87B
02595HKGENFLEET-B	-8.07x	78.96%	HK$12.23B
02627HKAB&B BIO-TECH-B	-46.87x	--	HK$11.54B
06855HKASCENTAGE	-6.45x	18.21%	HK$10.91B
01952HKEVEREST MED	-163.53x	324.61%	HK$10.15B
09887HKLEADS BIOLABS-B	-32.65x	8.67%	HK$10.03B
02493HKMABWELL-B	-8.62x	--	HK$9.33B
06938HKRIBOLIFE-B	-47.15x	29.88%	HK$9.21B
02616HKCSTONE PHARMA-B	-18.71x	1.72%	HK$9.03B
01672HKASCLETIS-B	-12.53x	78.59%	HK$8.54B
09966HKALPHAMAB-B	-39.62x	--	HK$8.03B
01779HKLONGBIO-B	-31.18x	--	HK$7.76B
02171HKCARSGEN-B	-72.05x	51.12%	HK$7.40B
02335HKMICOT PHARMA-B	-17.22x	37.50%	HK$7.23B
02256HKABBISKO-B	-11.67x	300.95%	HK$6.27B
06872HKTENNOR THERAP-B	-36.57x	--	HK$5.87B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.